Minerva Neurosciences, Inc. Gains 58.19%
Fri, Aug 26, 2022 at 07:02 PM
Minerva Neurosciences, Inc. (NERV:NASDAQ) shot up at $10.33, representing a gain of 58.2%. On Fri, Aug 26, 2022, NERV:NASDAQ hit a New 2-Week High of $10.33. The stock got featured on our News Catalysts scanner on Mon, Aug 22, 2022 at 08:32 AM in the 'BIOTECH' category. From Fri, Aug 12, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days
About Minerva Neurosciences, Inc. (NERV:NASDAQ)
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.
Top 10 Gainers:
- Micro Focus International plc (MFGP:NYSE), 92.01%
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 58.19%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- The OLB Group, Inc. (OLB:NASDAQ), 43.22%
- China Green Agriculture, Inc. (CGA:NYSE), 35.5%
- Farfetch Limited (FTCH:NYSE), 26.1%
- The L.S. Starrett Company (SCX:NYSE), 22.53%
- Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A) (OG:NYSE), 17.95%
- Direxion Daily Semiconductor Bear 3X Shares (SOXS:NYSE), 17.67%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 17.59%